IsoPlexis Investor Relations Material
Latest events
Status Update
IsoPlexis
Access the full event backlog
Slides, Transcripts, and Reports from over 8,000 public companies
IsoPlexis Corporation is a life sciences company that provides solutions for the development of curative medicines and personalized therapeutics for orphan diseases. The company's system enables faster and more accurate drug discovery by identifying compounds that will pass preclinical testing, reducing clinical trials costs and speeding to market. With a platform approach to drug discovery, IsoPlexis has built a robust discovery team with an experienced leadership team and institutional knowledge.
Latest articles
NIBE: Creating Millionaires and a Greener Future
NIBE, just like IKEA, was founded in a rural part of Sweden called Småland. The company offers a wide range of pumps, wood stoves, and solar panels.
6 Dec 2023
The Story of Jensen Huang and Nvidia
When looking at NVIDIA’s Jensen Huang today, it is easy to stereotype him as your archetypical big tech CEO. He doesn’t wear suits like a Wall Street Chairman, instead opting to wear his now-iconic leather jackets and casual polo shirts.
6 Dec 2023
Neglect of Probability: A Hidden Risk in Decision Making
The concept of "probability" should take center stage in our decision-making processes.
4 Dec 2023
Ticker symbol
ISO
Country
🇺🇸 United States